Clinical Study
Pulmonary Arterial Hypertension in Patients with Primary Sjögren’s Syndrome
Table 2
Comparison of demographic and clinical features in pSS patients with and without pulmonary artery hypertension.
| | pSS with PAH (, 23.4%) | pSS without PAH (, 76.6%) | value |
| Age (mean) | 41.6 | 59.2 | 0.04 | Duration of disease (years) | 4.3 | 9.5 | 0.04 | Dry eyes | 10 (90.9%) | 29 (80.6%) | 0.424 | Dry mouth | 9 (23.1%) | 30 (76.9%) | 0.907 | Arthralgia | 9 (81.8%) | 33 (91.7%) | 0.354 | CNS involvement | 1 (9.1%) | 0 (0%) | 0.675 | Raynaud’s phenomenon | 1 (9.1%) | 7 (19.4%) | 0.424 | Anti-Ro Ab | 7 (63.6%) | 21 (58.3%) | 0.754 | Anti-La Ab | 4 (36.4%) | 16 (44.4%) | 0.635 | C-reactive protein | 3 (27.3%) | 8 (22.2%) | 0.729 | ESR | 5 (45.5%) | 13 (36.1%) | 0.577 |
|
|